Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome

Kidney International

Volumn 77, Issue 8, 2010, Pages 669-680

  Oliver, Juan A ^a   Verna, Elizabeth C ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Clinical nephrology; Liver failure; Na transport; Physiology; Vascular disease

Indexed keywords

RENIN; SODIUM;

APPETITE; ARTERIAL PRESSURE; BODY WEIGHT; DRINKING BEHAVIOR; EDEMA; EXTRACELLULAR SPACE; HEART RATE; HEPATIC ARTERY; HEPATORENAL SYNDROME; HUMAN; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER FAILURE; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PRIORITY JOURNAL; REVIEW; SENSOR; SENSORY NERVE; SODIUM BALANCE; SODIUM INTAKE; SODIUM RETENTION; SODIUM TRANSPORT; THIRST; VASCULAR RESISTANCE;

BODY FLUIDS; FIBROSIS; HEPATORENAL SYNDROME; HUMANS; HYPERNATREMIA; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS;

EID: 77950517110     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.4     Document Type: Review

References (167)

1. Eisenmenger WJ, Blondheim SH, Bongiovanni AM et al. Electrolyte studies on patients with cirrhosis of the liver. J Clin Invest 1950; 29: 1491-1499.
2. Gines P, Cardenas A, Arroyo V, et al., Management of cirrhosis and ascites. N Engl J Med 2004; 350: 1646-1654.
3. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006; 55(Suppl 6): vi1-vi12.
4. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-856.
5. Moore KP, Wong F, Gines P et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-266.
6. Bonventre JV, Leaf A. Sodium homeostasis: steady states without a set point. Kidney Int 1982; 21: 880-883.
7. Pratt JH, Luft FC. The effect of extremely high sodium intake on plasma renin activity, plasma aldosterone concentration, and urinary excretion of aldosterone metabolites. J Lab Clin Med 1979; 93: 724-729.
8. Bosch J, Arroyo V, Betriu A et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980; 78: 92-99. (Pubitemid 10216855)
9. Epstein M, Berk DP, Hollenberg NK et al. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970; 49: 175-185.
10. Volpe M, Tritto C, DeLuca N et al. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 1993; 88(4 Part 1): 1620-1627.
11. Koppel MH, Coburn JW, Mims MM et al. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med 1969; 280: 1367-1371.
12. McDonald FD, Brennan LA, Turcotte JG. Severe hypertension and elevated plasma renin activity following transplantation of 'hepatorenal donor' kidneys into anephric recipients. Am J Med 1973; 54: 39-43.
13. Wong F, Sniderman K, Liu P et al. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997; 112: 899-907.
14. Quiroga J, Sangro B, Nunez M et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995; 21: 986-994.
15. Orloff MJ, Orloff MS, Orloff SL et al. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites. J Am Coll Surg 1997; 184: 557-570.
16. Ochs A, Rossle M, Haag K et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-1197.
17. Canzanello VJ, Textor SC, Taler SJ et al. Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. J Am Soc Nephrol 1995; 5: 1910-1917.
18. Iwatsuki S, Popovtzer MM, Corman JL et al. Recovery from 'hepatorenal syndrome' after orthotopic liver transplantation. N Engl J Med 1973; 289: 1155-1159.
19. Shusterman B, McHedishvili G, Rosner MH. Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience. Transplant Proc 2007; 39: 1496-1500.
20. Cassinello C, Moreno E, Gozalo A et al. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci 2003; 48: 179-186.
21. Lieberman FL, Reynolds TB. Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure. J Clin Invest 1967; 46: 1297-1308.
22. Gauer OH, Henry JP. Circulatory basis of fluid volume control. Physiol Rev 1963; 43: 423-481.
23. Eisenmenger WJ. Role of sodium in the formation and control of ascites in patients with cirrhosis. Ann Intern Med 1952; 37: 261-272.
24. Papper S. The role of the kidney in Laennec's cirrhosis of the liver. Medicine (Baltimore) 1958; 37: 299-316.
25. Lieberman FL, Ito S, Reynolds TB. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis. J Clin Invest 1969; 48: 975-981.
26. Lieberman FL, Denison EK, Reynolds TB. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: The overflow theory of ascites formation. Ann NY Acad Sci 1970; 170: 202-212.
27. Levy M. Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am J Physiol 1977; 233: F572-F585. (Pubitemid 8259549)
28. Schrier RW, Arroyo V, Bernardi M et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157.
29. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279-1290.
30. Martin PY, Ohara M, Gines P et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998; 101: 235-242.
31. Linas SL, Anderson RJ, Guggenheim SJ et al. Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis. Kidney Int 1981; 20: 173-180.
32. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244: G52-G57.
33. Fernandez-Munoz D, Caramelo C, Santos JC et al. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites. Am J Physiol 1985; 249(3 Part 1): G316-G320.
34. Ruiz-del-Arbol L, Monescillo A, Jimenez W et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997; 113: 579-586.
35. Paton RR, Kane RE. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharmacol 1977; 17: 243-251.
36. Marangoni E, Oddone A, Surian M et al. Effect of high-dose furosemide in refractory congestive heart failure. Angiology 1990; 41: 862-868.
37. Dormans TP, Gerlag PG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996; 17: 1867-1874.
38. Wilson JR, Reichek N, Dunkman WB et al. Effect of diuresis on the performance of the failing left ventricle in man. Am J Med 1981; 70: 234-239.
39. Yamauchi H, Hopper Jr J. Hypovolemic shock and hypotension as a complication in the nephrotic syndrome. Report of the ten cases. Ann Intern Med 1964; 60: 242-254.
40. Gornel DL, Lancestremere RG, Papper S et al. Acute changes in renal excretion of water and solute in patients with Laennec's cirrhosis, induced by the administration of the pressor amine, metaraminol. J Clin Invest 1962; 41: 594-603.
41. Laragh JH, Cannon PJ, Bentzel CJ et al. Angiotensin II, norepinephrine, and renal transport of electrolytes and water in normal man and in cirrhosis with ascites. J Clin Invest 1963; 42: 1179-1192.
42. Gulberg V, Bilzer M, Gerbes AL. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology 1999; 30: 870-875.
43. Duffin JM. Why does cirrhosis belong to Laennec? CMAJ 1987; 137: 393-396.
44. Burnstock G. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 1999; 194(Part 3): 335-342.
45. Nauli SM, Kawanabe Y, Kaminski JJ et al. Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 2008; 117: 1161-1171.
46. White CR, Frangos JA. The shear stress of it all: the cell membrane and mechanochemical transduction. Philos Trans R Soc Lond B Biol Sci 2007; 362: 1459-1467.
47. Mazbar SA, Wiedemann E, Humphreys MH. Mechanism of the natriuretic effect of unilateral carotid artery traction in the rat. J Am Soc Nephrol 1990; 1: 266-271.
48. Karim F, Poucher SM, Summerill RA. Effects of small changes in carotid sinus pressure on renal haemodynamics and function in dogs. J Physiol 1989; 417: 295-305.
49. Thames MD. Contribution of cardiopulmonary baroreceptors to the control of the kidney. Fed Proc 1978; 37: 1209-1213.
50. Gauer OH, Henry JP, Behn C. The regulation of extracellular fluid volume. Annu Rev Physiol 1970; 32: 547-595.
51. Reinhardt HW, Eisele R, Kaczmarczyk G et al. The control of sodium excretion by reflexes from the low pressure system independent of adrenal activity. Experiments on concious dogs. Pflugers Arch 1980; 384: 171-176.
52. Keeler R. Natriuresis after unilateral stimulation of carotid receptors in unanesthetized rats. Am J Physiol 1974; 226: 507-511.
53. Davis JO. The control of renin release. Am J Med 1973; 55: 333-350.
54. Gomez RA, Sequeira Lopez ML. Who and where is the renal baroreceptor? The connexin hypothesis. Kidney Int 2009; 75: 460-462.
55. Goetz KL, Hermreck AS, Slick GL et al. Atrial receptors and renal function in conscious dogs. Am J Physiol 1970; 219: 1417-1423.
56. Nafz B, Stegemann J, Bestle MH et al. Antihypertensive effect of 0.1-Hz blood pressure oscillations to the kidney. Circulation 2000; 101: 553-557.
57. Rosenmeier JB, Hansen J, Gonzalez-Alonso J. Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 2004; 558(Part 1): 351-365.
58. Daniels BS, Hostetter TH. Effects of dietary protein intake on vasoactive hormones. Am J Physiol 1990; 258(5 Part 2): R1095-R1100.
59. Lang F, Ottl I, Haussinger D et al. Renal hemodynamic response to intravenous and oral amino acids in animals. Semin Nephrol 1995; 15: 415-418.
60. Bie P, Wamberg S, Kjolby M. Volume natriuresis vs. pressure natriuresis. Acta Physiol Scand 2004; 181: 495-503.
61. Watkins Jr L, Burton JA, Haber E et al. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 1976; 57: 1606-1617.
62. Curtiss C, Cohn JN, Vrobel T et al. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978; 58: 763-770.
63. Anand IS, Ferrari R, Kalra GS et al. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989; 80: 299-305.
64. Cody RJ, Covit AB, Schaer GL et al. Sodium and water balance in chronic congestive heart failure. J Clin Invest 1986; 77: 1441-1452.
65. Miller Jr ED, Samuels AI, Haber E et al. Inhibition of angiotensin conversion in experimental renovascular hypertension. Science 1972; 177: 1108-1109.
66. Freeman RH, Davis JO, Seymour AA. Volume and vasoconstriction in experimental renovascular hypertension. Fed Proc 1982; 41: 2409-2414.
67. Seymour AA, Davis JO, Freeman RH et al. Sodium and angiotensin in the pathogenesis of experimental renovascular hypertension. Am J Physiol 1981; 240: H788-H792.
68. Gavras H, Brunner HB, Vaughan ED et al. Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 1973; 180: 1369-1371.
69. Meyer P, Ecoiffier J, Alexandre JM et al. Prognostic value of plasma renin activity in renovascular hypertension. Circulation 1967; 36: 570-576.
70. Melman A, Donohue JP, Weinberger MH et al. Improved diagnostic accuracy of renal venous renin ratios with stimulation of renin release. J Urol 1977; 117: 145-149.
71. Grim CE, Luft FC, Weinberger MH et al. Sensitivity and specificity of screening tests for renal vascular hypertension. Ann Intern Med 1979; 91: 617-622.
72. Oliver JA, Pinto J, Sciacca RR et al. Increased renal secretion of norepinephrine and prostaglandin E2 during sodium depletion in the dog. J Clin Invest 1980; 66: 748-756.
73. Luft FC, Klatte EC, Weyman AE et al. Cardiopulmonary effects of volume expansion in man: radiographic manifestations. AJR Am J Roentgenol 1985; 144: 289-293.
74. Rocchini AP, Gallagher KP, Botham MJ et al. Prevention of fatal hemorrhagic shock in dog by pretreatment with chronic high-salt diet. Am J Physiol 1985; 249(3 Part 2): H577-H584.
75. Liard JF. Haemodynamics and body fluid volumes in response to fluid loading in conscious dogs: non-excretory renal influences. Clin Sci Mol Med 1976; 51: 243-255.
76. Anand IS, Chandrashekhar Y, Ferrari R et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 1992; 86: 12-21.
77. Anand IS, Chandrashekhar Y, Ferrari R et al. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993; 70: 357-362.
78. Smith HJ, Oriol A, Morch J et al. Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol. Circulation 1967; 35: 1084-1091.
79. Guazzi MD, Agostoni P, Perego B et al. Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 1994; 72: 534-539.
80. Levy M, Allotey JB. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J Lab Clin Med 1978; 92: 560-569.
81. Levy M, Maher E, Wexler MJ. Euvolemic cirrhotic dogs in sodium balance maintain normal systemic hemodynamics. Can J Physiol Pharmacol 1988; 66: 80-83.
82. Tristani FE, Cohn JN. Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion. J Clin Invest 1967; 46: 1894-1906.
83. Talor Z. Blunted pressor response to volume load in conscious dogs with chronic bile duct ligation. Med Biol 1982; 60: 217-220.
84. Luca A, Garcia-Pagan JC, de Lacy AM et al. Effects of end-to-side portacaval shunt and distal splenorenal shunt on systemic and pulmonary haemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 1999; 14: 1112-1118.
85. Kostreva DR, Castaner A, Kampine JP. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity. Am J Physiol 1980; 238: R390-R394.
86. Lang F, Ottl I, Haussinger D. Influence of hepatic innervation on renal glomerular filtration rate. Pflugers Arch 1993; 425: 268-271.
87. DiBona GF, Sawin LL. Hepatorenal baroreflex in cirrhotic rats. Am J Physiol 1995; 269(1 Part 1): G29-G33.
88. Lang F, Tschernko E, Schulze E et al. Hepatorenal reflex regulating kidney function. Hepatology 1991; 14(4 Part 1): 590-594.
89. Morita H, Matsuda T, Furuya F et al. Hepatorenal reflex plays an important role in natriuresis after high-NaCl food intake in conscious dogs. Circ Res 1993; 72: 552-559.
90. Perlmutt JH, Aziz O, Haberich FJ. A comparison of sodium excretion in response to infusion of isotonic saline into the vena porta and vena cava of conscious rats. Pflugers Arch 1975; 357: 1-14.
91. Daly JJ, Roe JW, Horrocks P. A comparison of sodium excretion following the infusion of saline into systemic and portal veins in the dog: evidence for a hepatic role in the control of sodium excretion. Clin Sci 1967; 33: 481-487.
92. Passo SS, Thornborough JR, Rothballer AB. Hepatic receptors in control of sodium excretion in anesthetized cats. Am J Physiol 1973; 224: 373-375.
93. Morita H, Fujiki N, Miyahara T et al. Hepatoportal bumetanide-sensitive K(+)-sensor mechanism controls urinary K(+) excretion. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1134-R1139.
94. Chwalbinska-Moneta J. Role of hepatic portal osmoreception in the control of ADH release. Am J Physiol 1979; 236: E603-E609.
95. Haberich FJ. Osmoreception in the portal circulation. Fed Proc 1968; 27: 1137-1141.
96. Liard JF, Dolci W, Vallotton MB. Plasma vasopressin levels after infusions of hypertonic saline solutions into the renal, portal, carotid, or systemic circulation in conscious dogs. Endocrinology 1984; 114: 986-991.
97. Nicou A, Serriere V, Prigent S et al. Hypothalamic vasopressin release and hepatocyte Ca2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow. FASEB J 2003; 17: 1901-1903.
98. Blake WD, Lin KK. Hepatic portal vein infusion of glucose and sodium solutions on the control of saline drinking in the rat. J Physiol 1978; 274: 129-139.
99. Rogers RC, Novin D, Butcher LL. Hepatic sodium and osmoreceptors activate neurons in the ventrobasal thalamus. Brain Res 1979; 168: 398-403.
100. Tordoff MG, Schulkin J, Friedman MI. Hepatic contribution to satiation of salt appetite in rats. Am J Physiol 1986; 251(6 Part 2): R1095-R1102.
101. Tordoff MG, Schulkin J, Friedman MI. Further evidence for hepatic control of salt intake in rats. Am J Physiol 1987; 253(3 Part 2): R444-R449.
102. Deems RO, Friedman MI. Sodium chloride preference is altered in a rat model of liver disease. Physiol Behav 1988; 43: 521-525.
103. Lane JR, Purhar KK, Fitts DA. Drinking in sodium-depleted rats with bile duct, vena cava or portal vein obstruction. Physiol Behav 1997; 62: 1145-1154.
104. Schramek A, Better OS, Brook JG et al. New observations in the clinical spectrum of the Budd-Chiari Syndrome. Ann Surg 1974; 180: 368-372.
105. Orloff MJ, Spitz BR, Wall MH et al. Experimental ascites. iv. Comparison of the effects of end-to-side and side-to-side portacaval shunts on intractable ascites. Surgery 1964; 56: 784-799.
106. Levy M. Renal function in dogs with acute selective hepatic venous outflow block. Am J Physiol 1974; 227: 1074-1083.
107. Campbell V, Greig PD, Cranford J et al. A comparison of acute reversible pre-and postsinusoidal portal hypertension on salt and water retention in the dog. 1982; 2: 54-58.
108. Levy M. Renal function during acute graded elevation of portal venous pressure. Am J Physiol 1974; 227: 1084-1087.
109. Unikowsky B, Wexler MJ, Levy M. Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites. J Clin Invest 1983; 72: 1594-1604.
110. Wolfman Jr EF, Zuidema GD, Child III CG. Urinary sodium and aldosterone excretion following portocaval shunts for cirrhosis of liver and portal hypertension: effect of end-to-side and side-to-side anastomoses in 16 cases. Ann Surg 1966; 164: 538-546.
111. Ariyan S, Sweeney T, Kerstein MD. The hepatorenal syndrome: recovery after portacaval shunt. Ann Surg 1975; 181: 847-849.
112. Brensing KA, Textor J, Strunk H et al. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 1997; 349: 697-698. (Pubitemid 27107750)
113. Testino G, Ferro C, Sumberaz A et al. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 2003; 50: 1753-1755.
114. Lee KC, Miller RE. The hepatic vagus nerve and the neural regulation of insulin secretion. Endocrinology 1985; 117: 307-314.
115. Fukaya M, Mizuno A, Arai H et al. Mechanism of rapid-phase insulin response to elevation of portal glucose concentration. Am J Physiol Endocrinol Metab 2007; 293: E515-E522.
116. Imai J, Katagiri H, Yamada T et al. Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 2008; 322: 1250-1254.
117. Bernal-Mizrachi C, Xiaozhong L, Yin L et al. An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab 2007; 5: 91-102.
118. Warne JP, Foster MT, Horneman HF et al. Afferent signalling through the common hepatic branch of the vagus inhibits voluntary lard intake and modifies plasma metabolite levels in rats. J Physiol 2007; 583(Part 2): 455-467.
119. Uno K, Katagiri H, Yamada T et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 2006; 312: 1656-1659.
120. Ashton JH, Iwamoto GA, Longhurst JC et al. Reflex cardiovascular depression induced by capsaicin injection into canine liver. Am J Physiol 1982; 242: H955-H960.
121. Rankin EB, Biju MP, Liu Q et al. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007; 117: 1068-1077.
122. Suzuki N, Obara N, Yamamoto M. Use of gene-manipulated mice in the study of erythropoietin gene expression. Methods Enzymol 2007; 435: 157-177.
123. Oda M, Yokomori H, Han JY. Regulatory mechanisms of hepatic microcirculation. Clin Hemorheol Microcirc 2003; 29: 167-182.
124. Pannarale L, Onori P, Borghese F et al. Three-dimensional organization of the hepatic artery terminal branches: a scanning electron microscopic study of vascular corrosion casts of rat liver. Ital J Anat Embryol 2007; 112: 1-12.
125. Hanson KM, Johnson PC. Local control of hepatic arterial and portal venous flow in the dog. Am J Physiol 1966; 211: 712-720.
126. Greenway CV, Lawson AE, Stark RD. The effect of haemorrhage on hepatic artery and portal vein flows in the anesthetized cat. J Physiol 1967; 193: 375-379.
127. Lautt WW, McQuaker JE. Maintenance of hepatic arterial blood flow during hemorrhage is mediated by adenosine. Can J Physiol Pharmacol 1989; 67: 1023-1028.
128. Hirsch LJ, Rone AS. Hepatic arterial and portal flow in cardiogenic and hemorrhagic shock in awake dogs. Circ Shock 1982; 9: 17-26.
129. Rasmussen A, Skak C, Kristensen M et al. Preserved arterial flow secures hepatic oxygenation during haemorrhage in the pig. J Physiol 1999; 516(Part 2): 539-548.
130. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249(5 Part 1): G549-G556.
131. Gaffney GR, Betzer LK, Mow MT et al. Decrease in hepatic blood flow during furosemide-induced diuresis. Arch Int Pharmacodyn Ther 1979; 239: 155-160.
132. Richter S, Mucke I, Menger MD et al. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 2000; 279: G454-G462.
133. Schenk Jr WG, Mc DJ, Mc DK et al. Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals. Ann Surg 1962; 156: 463-471.
134. Moreno AH, Burchell AR, Rousselot LM et al. Portal blood flow in cirrhosis of the liver. J Clin Invest 1967; 46: 436-445.
135. Aoki T, Imamura H, Kaneko J et al. Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis. Liver Transpl 2005; 11: 684-691.
136. Hanna SS, Maheshwari Y. Effect of portal vein occlusion on liver blood flow in normal and cirrhotic dogs. J Surg Res 1986; 41: 293-300.
137. Ming Z, Fan YJ, Yang X et al. Blockade of intrahepatic adenosine receptors improves urine excretion in cirrhotic rats induced by thioacetamide. J Hepatol 2005; 42: 680-686.
138. Ming Z, Fan YJ, Yang X et al. Contribution of hepatic adenosine A1 receptors to renal dysfunction associated with acute liver injury in rats. Hepatology 2006; 44: 813-822.
139. Stanley AJ, Forrest EH, Dabos K et al. Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites. Gastroenterology 1998; 115: 406-411.
140. Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 2006; 5: 247-264.
141. Cohen MM, Sitar DS, McNeill JR et al. Vasopressin and angiotensin on resistance vessels of spleen, intestine, and liver. Am J Physiol 1970; 218: 1704-1706.
142. Oliver JA, Sciacca RR, Le Cren G et al. Modulation by prostaglandins of the renal vascular action of arginine vasopressin. Prostaglandins 1982; 24: 641-656.
143. Kerr JC, Reynolds DG, Swan KG. Vasopressin and canine hepatic arterial blood flow. J Surg Res 1977; 23: 166-171.
144. Bynum TE, Fara JW. Hepatic artery response to vasopressin. Am J Physiol 1980; 239: G378-G381.
145. Lautt WW. Afferent and efferent neural roles in liver function. Prog Neurobiol 1983; 21: 323-348.
146. Uyama N, Geerts A, Reynaert H. Neural connections between the hypothalamus and the liver. Anat Rec A Discov Mol Cell Evol Biol 2004; 280: 808-820.
147. Holzer P. Acid-sensitive ion channels and receptors. Handb Exp Pharmacol 2009; 194: 283-332.
148. O'Neil RG, Heller S. The mechanosensitive nature of TRPV channels. Pflugers Arch 2005; 451: 193-203.
149. Dersjant-Li Y, Verstegen MW, Jansman A et al. Changes in oxygen content and acid-base balance in arterial and portal blood in response to the dietary electrolyte balance in pigs during a 9-h period after a meal. J Anim Sci 2002; 80: 1233-1239.
150. Levy M, Wexler MJ. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis. Am J Physiol 1987; 253(4 Part 2): F664-F671.
151. Berthoud HR. Anatomy and function of sensory hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol 2004; 280: 827-835.
152. Kjaer M, Jurlander J, Keiding S et al. No reinnervation of hepatic sympathetic nerves after liver transplantation in human subjects. J Hepatol 1994; 20: 97-100.
153. Colle I, Van Vlierberghe H, Troisi R et al. Transplanted liver: consequences of denervation for liver functions. Anat Rec A Discov Mol Cell Evol Biol 2004; 280: 924-931.
154. Cereda JM, Roulot D, Braillon A et al. Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis. J Hepatol 1989; 9: 246-251.
155. Garcia-Pagan JC, Salmeron JM, Feu F et al. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology 1994; 19: 1095-1099.
156. Okumura H, Aramaki T, Katsuta Y et al. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites. Am J Gastroenterol 1991; 86: 46-52.
157. Eisenmenger WJ, Ahrens EH, Blondheim SH et al. The effect of rigid sodium restriction in patients with cirrhosis of the liver and ascites. J Lab Clin Med 1949; 34: 1029-1038.
158. Ricketts WE, Eichelberger L, Kirsner JB. Observations on the alterations in electrolytes and fluid balance in patients with cirrhosis of the liver with a without ascites. J Clin Invest 1951; 30: 1157-1170.
159. Gabuzda Jr GJ, Traeger HS, Davidson CS. Hepatic cirrhosis: effect of sodium chloride administration and restriction and of abdominal paracentesis on electrolyte and water balance. J Clin Invest 1954; 33: 780-789.
160. Sherlock S, Shaldon S. The aetiology and management of ascites in patients with hepatic cirrhosis: a review. Gut 1963; 4: 95-105.
161. Simpson IA, Rae AP, Simpson K et al. Ultrafiltration in the management of refractory congestive heart failure. Br Heart J 1986; 55: 344-347.
162. Desai KV, Laine GA, Stewart RH et al. Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol 2008; 294: H2428-H2434.
163. Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991; 68: 1713-1721.
164. Reynolds TB. Hepatic circulatory changes after shunt surgery. Ann NY Acad Sc 1970; 170: 379-391.
165. Redeker AG, Geller HM, Reynolds TB. Hepatic wedge pressure, blood flow, vascular resistance and oxygen consumption in cirrhosis before and after end-to-side portacaval shunt. J Clin Invest 1958; 37: 606-618.
166. Zimmon DS, Kessler RE. Effect of portal venous blood flow diversion on portal pressure. J Clin Invest 1980; 65: 1388-1397.
167. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007; 100: 174-190.